Fu, L. & Lee, C. C. The circadian clock: pacemaker and tumour suppressor.Nat. Rev. Cancer 3, 350–361 (2003).
Yu, E. A. & Weaver, D. R. Disrupting the circadian clock: gene-specifc eﬀects on aging, cancer, and other phenotypes. Aging 3, 479–493 (2011).
 Bugge, A. et al. REV-ERBα and REV-ERBβ coordinately protect the circadian clock and normal metabolic function. Genes Dev. 26, 657–667 (2012).
Currie, E., Schulze, A., Zechner, R., Walther, T. C. & Farese, R. V. Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 18, 153–161 (2013).
White, E. Deconvoluting the context-dependent role for autophagy in cancer.Nat. Rev. Cancer 12, 401–410 (2012).
Rubinsztein, D. C., Codogno, P. & Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11,709–730 (2012).
Woldt, E. et al. REV-ERB-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat. Med. 19, 1039–1046(2013).